More biomarkers do not automatically mean more insight
Why interpretation, repeatability and actionability matter more than the length of the laboratory panel.
Measurement has noise
Biomarkers vary with timing, illness, hydration, recent exercise, medication and laboratory method. A single number can be less stable than it looks.
Prioritise established risk
Blood pressure, glycaemic status and lipid-related cardiovascular risk remain central to prevention. Performance and body-composition measures can add useful functional context.
Emerging markers need humility
Epigenetic clocks, glycan measures and proprietary health scores are promising research-adjacent tools, but should not be treated as a diagnosis or a complete measure of ageing.
Repeat only when it helps
Longitudinal tracking is valuable when the same method is used and the result informs a real decision. Repeating everything simply because it can be measured adds cost and noise.
Sources & further reading
Interpretation matters: evidence applies to the population, intervention and outcome actually studied. We avoid converting population-level findings into individual promises.